|
Match
|
Document |
Document Title |
|
|
US20100333218 |
TRANSGENIC PROTEINS FROM MULTI-GENE SYSTEMS, METHODS, COMPOSITIONS, USES AND THE LIKE RELATING THERETO
A non-human transgenic mammalian animal, as described above, contains one or more exogenous double stranded DNA sequence(s) stably integrated into the genome of the animal, which comprises... |
|
|
US20150067899 |
Multiple Inducible Gene Regulation System
The present invention relates to the field of biotechnology or genetic engineering. More specifically, the present invention relates to a multiple inducible gene regulation system that functions... |
|
|
US20110023141 |
GENOMIC EDITING OF GENES INVOLVED WITH PARKINSON'S DISEASE
The present invention provides genetically modified animals and cells comprising edited chromosomal sequences encoding proteins associated with Parkinson's disease. In particular, the animals or... |
|
|
US20110023158 |
BOVINE GENOME EDITING WITH ZINC FINGER NUCLEASES
The present invention provides a genetically modified bovine or cell comprising at least one edited chromosomal sequence. In particular, the chromosomal sequence is edited using a zinc finger... |
|
|
US20110283375 |
Transgenic Prothrombin And Related Thrombin Precursors And Transgenics, Methods, Compositions, Uses And The Like Relating Thereto
The invention provides, among other things, activatable prothrombin, compositions comprising prothrombin, transgenic organisms for making prothrombin, methods for making the transgenic organisms,... |
|
|
US20110023139 |
GENOMIC EDITING OF GENES INVOLVED IN CARDIOVASCULAR DISEASE
The present invention provides genetically modified animals and cells comprising edited chromosomal involved in cardiovascular disease. In particular, the animals or cells are generated using a... |
|
|
US20110023151 |
GENOME EDITING OF ABC TRANSPORTERS
The present invention provides genetically modified animals and cells comprising edited chromosomal sequences encoding ABC transporter proteins. In particular, the animals or cells are generated... |
|
|
US20140201857 |
HORNLESS LIVESTOCK
Compositions and methods for making livestock with a polled allele are presented, including migrating a polled allele into a bovine species without changing other genes or chromosomal portions. |
|
|
US20110016543 |
GENOMIC EDITING OF GENES INVOLVED IN INFLAMMATION
The present invention provides genetically modified animals and cells comprising edited chromosomal sequences encoding inflammation-related proteins. In particular, the animals or cells are... |
|
|
US20110126297 |
TRANSGENIC ANIMAL WITH MONOCYTE CHEMOTACTIC PROTEIN 1 PROMOTER
The present invention relates to a transgenic animal, which comprises in its genome a recombinant polynucleotide encoding one or more reporter proteins and a monocyte chemotactic protein-1 (MCP-1)... |
|
|
US20110023146 |
GENOMIC EDITING OF GENES INVOLVED IN SECRETASE-ASSOCIATED DISORDERS
The present invention provides genetically modified animals and cells comprising edited chromosomal sequences encoding proteins that are associated with a secretase disorder. In particular, the... |
|
|
US20130219533 |
PLA2G16 AS A TARGET FOR ANTIVIRAL COMPOUNDS
In some aspects, the invention provides compositions and methods for inhibiting viral infection. In some aspects, the invention provides compositions and methods useful for identifying antiviral... |
|
|
US20150150153 |
ARTIFICIAL OOCYTE ACTIVATION
The present invention provides novel methods for improving the efficiency of artificial activation of unfertilized mammalian oocytes by reducing the intracellular concentration of Zn2+ in the... |
|
|
US20140182005 |
SPERM CELL SEPARATION METHODS AND COMPOSITIONS CONTAINING SPERM CELL TARGETING LIGANDS FOR USE THEREIN
The present invention provides sperm cell targeting ligands, including DNA-binding proteins, that bind target molecules on the surface of, accessible from the surface of, or inside mammalian sperm... |
|
|
US20110023145 |
GENOMIC EDITING OF GENES INVOLVED IN AUTISM SPECTRUM DISORDERS
The present invention provides genetically modified animals and cells comprising edited chromosomal sequences encoding proteins associated with ASD. In particular, the animals or cells are... |
|
|
US20110023153 |
GENOMIC EDITING OF GENES INVOLVED IN ALZHEIMER'S DISEASE
The present invention provides genetically modified animals and cells comprising edited chromosomal sequences encoding proteins associated with AD. In particular, the animals or cells are... |
|
|
US20120167239 |
Novel ecdysone receptor/invertebrate retinoid X receptor-based inducible gene expression system
This invention relates to the field of biotechnology or genetic engineering. Specifically, this invention relates to the field of gene expression. More specifically, this invention relates to a... |
|
|
US20110016540 |
GENOME EDITING OF GENES ASSOCIATED WITH TRINUCLEOTIDE REPEAT EXPANSION DISORDERS IN ANIMALS
The present invention provides genetically modified animals and cells comprising edited chromosomal sequences encoding proteins that are associated with trinucleotide repeat expansion disorders.... |
|
|
US20120023599 |
GENOME EDITING OF CYTOCHROME P450 IN ANIMALS
The present invention provides genetically modified animals and cells comprising edited chromosomal sequences encoding cytochrome P450 (CYP) proteins. In particular, the animals or cells are... |
|
|
US20110023148 |
GENOME EDITING OF ADDICTION-RELATED GENES IN ANIMALS
The present invention provides genetically modified animals and cells comprising edited chromosomal sequences encoding proteins associated with addiction disorders. In particular, the animals or... |
|
|
US20140123330 |
CONTROL OF SEXUAL MATURATION IN ANIMALS
A genetically modified livestock animal comprising a genome that comprises inactivation of a neuroendocrine gene selective for sexual maturation, with the inactivation of the gene preventing the... |
|
|
US20100077491 |
Modulators of RNF5 and Uses Thereof
Provided herein are compositions and methods relating to the involvement of RNF5 in muscle wasting. |
|
|
US20120128682 |
APOLIPOPROTEIN L- I VARIANTS AND THEIR USE
An isolated human Apolipoprotein L-I corresponding to a wild type human Apolipoprotein sequence is modified by a deletion at its C-terminal end. |
|
|
US20120159653 |
GENOMIC EDITING OF GENES INVOLVED IN MACULAR DEGENERATION
The present invention provides genetically modified animals and cells comprising edited chromosomal sequences encoding proteins associated with MD. In particular, the animals or cells are... |
|
|
US20090133133 |
Transgenic Mice for Bioassay of Prions from Deer and Elk with Chronic Wasting Disease
The invention relates to the use of transgenic constructs to produce animal models for the study of chronic wasting disease. |
|
|
US20130031648 |
Use of Follistatin-Like Related Gene (FLRG) to Increase Muscle Mass
The present relates to use of follistatin-like related gene (FLRG) to increase muscle mass in a subject. As such, methods of ameliorating the severity of a pathologic condition characterized, at... |
|
|
US20080115234 |
Method for utilization of domestic ruminants with mycobacterium avium subspecies paratuberculosis disease to assess possible therapeutic modalities
The invention describes a concrete schema which allow domesticated ruminant with disease due to Mycobacterium avium subspecies paratuberculosis to serve as an animal model system in order to... |
|
|
US20110023147 |
GENOMIC EDITING OF PRION DISORDER-RELATED GENES IN ANIMALS
The present invention provides genetically modified animals and cells comprising edited chromosomal sequences encoding proteins that are associated with cognitive disorders. In particular, the... |
|
|
US20130131317 |
EXPRESSION OF SECRETED HUMAN ALPHA-FETOPROTEIN IN TRANSGENIC ANIMALS
The invention features a process of expressing secreted recombinant human alpha-fetoprotein (rHuAFP) in the milk or urine of transgenic mammals. |
|
|
US20120259093 |
EXPRESSION OF SECRETED HUMAN ALPHA-FETOPROTEIN IN TRANSGENIC ANIMALS
The invention features a process of expressing secreted recombinant human alpha-fetoprotein (rHuAFP) in the milk or urine of transgenic mammals. |
|
|
US20110077208 |
EXPRESSION OF SECRETED HUMAN ALPHA-FETOPROTEIN IN TRANSGENIC ANIMALS
The invention features a process of expressing secreted recombinant human alpha-fetoprotein (rHuAFP) in the milk or urine of transgenic mammals. |
|
|
US20110209229 |
Gene of porcine beta casein, a promoter of the same and the use thereof
The present invention provides a porcine beta-casein gene, a porcine beta-casein gene promoter, an expression vector comprising the same promoter, and a method for the production of a target... |
|
|
US20110016539 |
GENOME EDITING OF NEUROTRANSMISSION-RELATED GENES IN ANIMALS
The present invention provides genetically modified animals and cells comprising edited chromosomal sequences encoding proteins that are associated with neurotransmission disorders. In particular,... |
|
|
US20120185954 |
Mutant Receptors and Their Use in a Nuclear Receptor-Based Inducible Gene Expression
This invention relates to the field of biotechnology or genetic engineering. Specifically, this invention relates to the field of gene expression. More specifically, this invention relates to... |
|
|
US20110030072 |
GENOME EDITING OF IMMUNODEFICIENCY GENES IN ANIMALS
The present invention provides genetically modified animals and cells comprising edited chromosomal sequences encoding immunodeficiency proteins. In particular, the animals or cells are generated... |
|
|
US20110016541 |
GENOME EDITING OF SENSORY-RELATED GENES IN ANIMALS
The present invention provides genetically modified animals and cells comprising edited chromosomal sequences encoding proteins that are associated with nociception or taste disorders. In... |
|
|
US20110023143 |
GENOMIC EDITING OF NEURODEVELOPMENTAL GENES IN ANIMALS
The present invention provides genetically modified animals and cells comprising edited chromosomal sequences encoding proteins that are associated with neurodevelopmental disorders. In... |
|
|
US20050177883 |
Systems of transferring embryos and managing recipients
Provided herein are methods of managing embryo transfer programs, for instance bovine embryo transfer programs. Examples of such methods are referred to as “bred recipient transfer” programs, in... |
|
|
US20100125918 |
ENTEROVIRUS TYPE 71 PROTEIN AND METHOD FOR PRODUCTION
The invention provides a new type of a capsid protein VP1 of human enterovirus 71, named as MEL701-VP1 and functional/structural variants thereof, which is used for protection against enterovirus.... |
|
|
US20110023152 |
GENOME EDITING OF COGNITION RELATED GENES IN ANIMALS
The present invention provides genetically modified animals and cells comprising edited chromosomal sequences encoding proteins that are associated with cognitive disorders. In particular, the... |
|
|
US20080051328 |
Novel Muscle Growth Regulator
A muscle growth regulating factor includes polynucleotide and polypeptide sequences, promoter sequences, constructs comprising the sequences, and compositions for regulating muscle growth and... |
|
|
US20100024047 |
Prion-free transgenic ungulates
Transgenic and cloned ungulates and particularly cloned cattle are disclosed, wherein such cattle contain a deletion or disruption of the prion gene locus and do not express functional prion... |
|
|
US20120159654 |
GENOME EDITING OF GENES INVOLVED IN ADME AND TOXICOLOGY IN ANIMALS
The present invention provides genetically modified animals and cells comprising edited chromosomal sequences involved in ADME and toxicology. In particular, the animals or cells are generated... |
|
|
US20110023150 |
GENOME EDITING OF GENES ASSOCIATED WITH SCHIZOPHRENIA IN ANIMALS
The present invention provides genetically modified animals and cells comprising edited chromosomal sequences associated with schizophrenia. In particular, the animals or cells are generated using... |
|
|
US20110231943 |
TRANSGENIC ANIMALS AND USES THEREOF
In general, the invention features genetically modified non-human mammals (e.g., bovines and other ungulates), and methods of making these mammals. In particular, the invention features transgenic... |
|
|
US20110239314 |
Gene of porcine alpha-si casein, a promoter of the same and use thereof
The present invention relates to a porcine alpha-S1-casein gene, a porcine alpha-S1-casein gene promoter, an expression comprising the same promoter, and a method for the production of a target... |
|
|
US20120233715 |
HUMAN ARTIFICIAL CHROMOSOME VECTOR
A human artificial chromosome vector comprising a human antibody heavy chain gene, a human antibody light chain gene, and a human antibody surrogate light chain gene. |
|
|
US20120222143 |
GENETICALLY MODIFIED ANIMALS AND METHODS FOR MAKING THE SAME
Compositions and methods for use of TALENs to make genetically modified livestock are set forth. The methods may include reporters for selecting cells or embryos that have been modified by TALENs... |
|
|
US20110093965 |
PHOSPHOLIPASES, NUCLEIC ACIDS ENCODING THEM AND METHODS FOR MAKING AND USING THEM
The invention provides novel polypeptides having phospholipase activity, including, e.g., phospholipase A, B, C and D activity, patatin activity, phosphatidic acid phosphatases (PAP) and/or lipid... |
|
|
US20050155093 |
Rabbit nuclear cloning method and uses thereof
The invention concerns a method for producing non-human mammal embryos, in particular rabbit by nuclear cloning. The invention also concerns the mammals obtained and their uses. |